FDA: Statement on Medtronic's Voluntary Market Suspension of Their Sprint Fidelis Defibril

FOR IMMEDIATE RELEASE


October 15, 2007


Media Inquiries:Karen Riley 301-827-6242


Consumer Inquiries: 888-INFO-FDA